National construction firm Interserve has landed a contract to deliver a £15 million Medicines Manufacturing Innovation Centre in Scotland.

Located near Glasgow Airport in Inchinnan, Renfrewshire, the centre will help to establish the UK as a technology and innovation leader in small molecule pharmaceutical and fine chemical manufacturing.

CPI, an independent technology innovation centre, is leading the project in partnership with the University of Strathclyde, UKRI, Scottish Enterprise, and founding industry partners, AstraZeneca and GlaxoSmithKline.

The business works with partners across diverse markets in the UK and around the world, driving innovations forward and helping them to reduce the risk and cost associated with product development.


Commenting on the recent contract win, Interserve's Regional Director, Cameron Stewart said: "We are delighted to have been awarded this £15m project for the Medicines Manufacturing Innovation Centre. We look forward to strengthening our relationship with CPI, having recently delivered their National Biologics Manufacturing Centre in Darlington.

"The new centre is a really exciting, innovative project. We have an extensive track record in this sector and look forward to adding real value to the project through our extensive experience and capabilities in the healthcare and medical research sector. The facility will be market leading for the pharmaceutical industry and Interserve are pleased to be part of that."

Jerry Cooper, Project Director for the Medicines Manufacturing Innovation Centre, has expressed delight at Interserve's appointment and promised the project will be "a fundamental addition to the UK pharmaceutical manufacturing sector".

The design and scoping process will commence shortly.

(CM/MH)